Compare Honest Company Inc (HNST) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honest Company Inc vs BIO-TECHNE Corp — how do they compare? Honest Company Inc trades at $5.2 (market cap $561.10M), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: BIO-TECHNE Corp is far larger — about 20× Honest Company Inc's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Honest Company Inc pays none. Which is the better fit depends on your goals.
| HNST | TECH | |
|---|---|---|
Market Cap | $561.10M | $11.24B |
Sector | Consumer Staples | Health |
52-Week High | $5.46 | $72.29 |
52-Week Low | $2.10 | $43.31 |
Enterprise Value | $464.71M | $11.32B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HNST trades at $5.46, up 0.74% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported Q2 2026 EPS of $0.04, beating estimates, yet revenue declined to $342M in 2026 due to strategic exits. Net income remains negative at -$12M, with improving cash flow trends showing $34M net cash flow in 2026. Recent news highlights organic growth in wipes and personal care, but overall sales face pressure.
Outlook is mixed: strategic exits may bolster margins long-term, but persistent losses and high P/E of 48.83 pose valuation risks. Analyst consensus is cautious with 30% buy ratings. Key risks include execution on profitability and competitive pressures in personal care.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Honest Company Inc
The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.
Read more on HNST →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
